Xiao-Jun Huang,Shi-Ge Wang,Xia-Nan Guo,Wo-Tu Tian,Fei-Xia Zhan,Ze-Yu Zhu,Xiao-Meng Yin,Qing Liu,Kai-Li Yin,Xiao-Rong Liu,Yu Zhang,Zhen-Guo Liu,Xiao-Li Liu,Lan Zheng,Tian Wang,Li Wu,Tian-Yi Rong,Yan Wang,Mei Zhang,Guang-Hui Bi,Wei-Guo Tang,Chao Zhang,Ping Zhong,Chun-Yu Wang,Jian-Guang Tang,Wei Lu,Ru-Xu Zhang,Guo-Hua Zhao,Xun-Hua Li,Hua Li,Tao Chen,Hai-Yan Li,Xiao-Guang Luo,Yan-Yan Song,Hui-Dong Tang,Xing-Hua Luan,Hai-Yan Zhou,Bei-Sha Tang,Sheng-Di Chen,Li Cao

Abstract:Background Paroxysmal kinesigenic dyskinesia is a spectrum of involuntary dyskinetic disorders with high clinical and genetic heterogeneity. Mutations in proline-rich transmembrane protein 2 have been identified as the major pathogenic factor.Objectives We analyzed 600 paroxysmal kinesigenic dyskinesia patients nationwide who were identified by the China Paroxysmal Dyskinesia Collaborative Group to summarize the clinical phenotypes and genetic features of paroxysmal kinesigenic dyskinesia in China and to provide new thoughts on diagnosis and therapy.Methods The China Paroxysmal Dyskinesia Collaborative Group was composed of departments of neurology from 22 hospitals. Clinical manifestations and proline-rich transmembrane protein 2 screening results were recorded using unified paroxysmal kinesigenic dyskinesia registration forms. Genotype-phenotype correlation analyses were conducted in patients with and without proline-rich transmembrane protein 2 mutations. High-knee exercises were applied in partial patients as a new diagnostic test to induce attacks.Results Kinesigenic triggers, male predilection, dystonic attacks, aura, complicated forms of paroxysmal kinesigenic dyskinesia, clustering in patients with family history, and dramatic responses to antiepileptic treatment were the prominent features in this multicenter study. Clinical analysis showed that proline-rich transmembrane protein 2 mutation carriers were prone to present at a younger age and have longer attack duration, bilateral limb involvement, choreic attacks, a complicated form of paroxysmal kinesigenic dyskinesia, family history, and more forms of dyskinesia. The new high-knee-exercise test efficiently induced attacks and could assist in diagnosis.Conclusions We propose recommendations regarding diagnostic criteria for paroxysmal kinesigenic dyskinesia based on this large clinical study of paroxysmal kinesigenic dyskinesia. The findings offered some new insights into the diagnosis and treatment of paroxysmal kinesigenic dyskinesia and might help in building standardized paroxysmal kinesigenic dyskinesia clinical evaluations and therapies. (c) 2020 International Parkinson and Movement Disorder Society

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency

Phenotypic Overlap among Paroxysmal Dyskinesia Subtypes: Lesson from a Family with PRRT2 Gene Mutation.

Heterozygous KCNJ10 Variants Affecting Kir4.1 Channel Cause Paroxysmal Kinesigenic Dyskinesia

Exercise Test for Patients with New-Onset Paroxysmal Kinesigenic Dyskinesia

Novel mutation of the PRRT2 gene in two cases of paroxysmal kinesigenic dyskinesia: Two case reports

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

[Clinical Features and PRRT2 Gene Mutation in Paroxysmal Kinesigenic Dyskinesia].

Familial Paroxysmal Kinesigenic Dyskinesia is Associated with Mutations in the KCNA1 Gene

Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic Dyskinesia

Novel Missense Variant in the TMEM151A Gene Causing Paroxysmal Kinesigenic Dyskinesia: a Case Report with Literature Review

PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.

The Phenotypic And Genetic Spectrum Of Paroxysmal Kinesigenic Dyskinesia In China

Both Gain- and Loss-of-function Variants of KCNA1 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia

Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesignic dyskinesia

Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients.

A new genetic diagnosis strategy for paroxysmal kinesigenic dyskinesia: Targeted high‐throughput detection of PRRT2 gene c.649 locus

Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis.

Clinical and Genetic Analyses of 150 Patients with Paroxysmal Kinesigenic Dyskinesia.

Exome Sequencing Identifies Truncating Mutations in PRRT2 That Cause Paroxysmal Kinesigenic Dyskinesia

Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.